These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17041845)

  • 21. Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium.
    Kim YR; Kim SI; Hur JA; Kim YJ; Wie SH; Park YJ; Kang MW
    Ann Clin Lab Sci; 2007; 37(3):260-2. PubMed ID: 17709691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptogramin resistance and shared pulsed-field gel electrophoresis patterns in vanA-containing Enterococcus faecium and Enterococcus hirae isolated from humans and animals in Spain.
    Robredo B; Singh KV; Torres C; Murray BE
    Microb Drug Resist; 2000; 6(4):305-11. PubMed ID: 11272259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of vat(E)-carrying plasmids in Enterococcus faecium recovered from human and animal sources.
    Simjee S; Zhang Y; McDermott PF; Donabedian SM; Zervos MJ; Meng J
    Int J Antimicrob Agents; 2006 Sep; 28(3):200-5. PubMed ID: 16911866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork.
    Sørensen TL; Blom M; Monnet DL; Frimodt-Møller N; Poulsen RL; Espersen F
    N Engl J Med; 2001 Oct; 345(16):1161-6. PubMed ID: 11642232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
    Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
    Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
    Bozdogan B; Leclercq R
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in antimicrobial susceptibility of native Enterococcus faecium in chickens fed virginiamycin.
    McDermott PF; Cullen P; Hubert SK; McDermott SD; Bartholomew M; Simjee S; Wagner DD
    Appl Environ Microbiol; 2005 Sep; 71(9):4986-91. PubMed ID: 16151077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.
    Wang S; Guo Y; Lv J; Qi X; Li D; Chen Z; Zhang X; Wang L; Yu F
    BMC Microbiol; 2016 Oct; 16(1):246. PubMed ID: 27769188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
    Fantin B; Leclercq R; Garry L; Carbon C
    Antimicrob Agents Chemother; 1997 May; 41(5):931-5. PubMed ID: 9145847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of genetic diversity and incidence of virulence factors and antibiotic resistance among enterococcal populations from raw fruit and vegetable foods, water and soil, and clinical samples.
    Abriouel H; Omar NB; Molinos AC; López RL; Grande MJ; Martínez-Viedma P; Ortega E; Cañamero MM; Galvez A
    Int J Food Microbiol; 2008 Mar; 123(1-2):38-49. PubMed ID: 18180067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
    Jones RN; Ballow CH; Biedenbach DJ; Deinhart JA; Schentag JJ
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple-antibiotic resistance of Enterococcus spp. isolated from commercial poultry production environments.
    Hayes JR; English LL; Carr LE; Wagner DD; Joseph SW
    Appl Environ Microbiol; 2004 Oct; 70(10):6005-11. PubMed ID: 15466544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations.
    Aeschlimann JR; Zervos MJ; Rybak MJ
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2710-7. PubMed ID: 9756782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
    Summers M; Misenhimer GR; Antony SJ
    South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of streptogramin resistance in enterococci from animals: identification of vatD from animal sources in the USA.
    Jackson CR; Fedorka-Cray PJ; Barrett JB; Hiott LM; Woodley TA
    Int J Antimicrob Agents; 2007 Jul; 30(1):60-6. PubMed ID: 17532190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)].
    Betriu C; Valverde JF; Culebras E; Gómez M; Sánchez A; Palau ML; Picazo JJ
    Enferm Infecc Microbiol Clin; 1999; 17(7):335-9. PubMed ID: 10535185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining quinupristin/dalfopristin with other agents for resistant infections.
    Brown J; Freeman BB
    Ann Pharmacother; 2004 Apr; 38(4):677-85. PubMed ID: 14990776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinupristin/dalfopristin: a treatment option for vancomycin-resistant Enterococci.
    Kim MK; Nicolau DP; Nightingale CH; Quintiliani R
    Conn Med; 2000 Apr; 64(4):209-12. PubMed ID: 10812767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.